Trials / Completed
CompletedNCT01577563
Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).
Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis Receiving Treatment With Non- Steroidal Anti- Inflammatory Drugs.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,383 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
RATIONAL is a multinational, multicentre, observational, cross sectional study of adult patients in treatment with NSAID therapy for OA, RA or AS during for at least 2 weeks before study visit (at least one dose).
Detailed description
Prevalence study of gastrointestinal risk factors in patients with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis receiving treatment with non- steroidal anti- inflammatory drugs.
Conditions
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2012-04-16
- Last updated
- 2013-05-14
Locations
85 sites across 10 countries: Argentina, Colombia, Malaysia, Mexico, Philippines, Russia, South Korea, Thailand, Venezuela, Vietnam
Source: ClinicalTrials.gov record NCT01577563. Inclusion in this directory is not an endorsement.